FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Study aims to improve telehealth services for MS patients




















Spencer Platt/Getty Images


Elizabeth Morrison-Banks, MD, a health sciences clinical professor at the University of California, Riverside, has received a $100,000 grant from Genentech to conduct a study in hopes of developing a telehealth program for individuals with MS.
The study, titled “ Clinicians’ Online Neurology Network Empowering Communities through Telemedicine – Multiple Sclerosis (CONNECT-MS)," will cover a year in the lives of MS patients receiving care through telemedicine. The goal is to provide improved neurological care to MS patients who would otherwise be burdened with travel or live in underserved populations.

“People with advanced MS face additional barriers in traveling to an MS center, even if it is located nearby, because if they have a lot of disability, over time it tends to become increasingly difficult for them to leave their homes,” said Morrison-Banks. “So if we can bring the ‘medical home’ into people’s actual homes, we can meet multiple needs at the same time while allowing a safe and comfortable environment for the medical visit.”

The study will include MS patients in a control and intervention group. The intervention group will be visited by a nurse practitioner in their homes to review patient history and complete a neurological exam while communicating with a neuro-immunologist at Riverside through a telemedicine platform. Results in care quality will be compared in each group along with factors including quality of life, pain levels, fatigue, sexual satisfaction, bladder control, bowel control, visual impairment and mental health.

Nurse practitioners will visit participants a month after the study’s conclusion to make a HIPAA-compliant telemedicine visit with Morrison-Banks. The team will then analyze measurements taken to recommend a course of treatment.

“The goal is to determine whether the home telemedicine approach works as well as usual care—that is, office visits with the neuro-immunologist,” Morrison-Banks said. “This is a pilot study and it may not be able to show whether MS telemedicine in patients’ homes is better than usual care, but if it appears to be equivalent —and if patients and families like it better because of its convenience and comfort —then the pilot study will provide useful preliminary data to guide larger research studies in the future.”


Story Source: The above story is based on materials provided by CLINICALINNOVATION+TECHNOLOGY
Note: Materials may be edited for content and length
Click here to read original article

Labels:



Go to Newer News Go to Older News